2022 Annual Results - revised publication date | 21-Mar-2023 | 14:11 | RNS |
Notice of Results | 15-Mar-2023 | 07:00 | RNS |
EBT Share Purchase | 20-Feb-2023 | 14:47 | RNS |
EBT Share Purchase | 13-Feb-2023 | 15:06 | RNS |
EBT Share Purchase | 06-Feb-2023 | 17:42 | RNS |
EBT Share Purchase | 30-Jan-2023 | 15:17 | RNS |
Pre-Close Update | 25-Jan-2023 | 07:00 | RNS |
EBT Share Purchase | 23-Jan-2023 | 15:03 | RNS |
EBT Share Purchase | 16-Jan-2023 | 16:50 | RNS |
EBT Share Purchase | 09-Jan-2023 | 14:16 | RNS |
EBT Share Purchase | 29-Dec-2022 | 09:16 | RNS |
Director/PDMR Shareholding | 23-Dec-2022 | 08:51 | RNS |
Increased Purchase of Shares by EBT | 21-Dec-2022 | 14:46 | RNS |
EBT Share Purchase | 19-Dec-2022 | 15:06 | RNS |
EBT Share Purchase | 12-Dec-2022 | 14:11 | RNS |
Currency | UK Pounds |
Share Price | 705.00p |
Change Today | -25.00p |
% Change | -3.42 % |
52 Week High | 1,005.00 |
52 Week Low | 705.00 |
Volume | 20,789 |
Shares Issued | 38.27m |
Market Cap | £269.83m |
RiskGrade | 80 |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Strong Buy | 4 |
Buy | 2 |
Neutral | 0 |
Sell | 0 |
Strong Sell | 0 |
Total | 6 |
Latest | Previous | |
---|---|---|
Final | Final | |
Ex-Div | 12-May-22 | 06-May-21 |
Paid | 27-May-22 | 21-May-21 |
Amount | 10.00p | 6.00p |
Time | Volume / Share Price |
16:20 | 5 @ 709.50p |
16:12 | 123 @ 705.00p |
15:40 | 1,510 @ 711.00p |
14:30 | 231 @ 712.50p |
14:28 | 624 @ 713.70p |
Chair | Anthony Townsend |
CEO | Anthony (Tony) Dalwood |
CFO | Kevin Acton |
You are here: research